Submitted:
20 March 2026
Posted:
20 March 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results

3.1. Case Description
3.1.1. Patient 1
3.1.2. Case 2
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A
| Test |
Normal value reference |
Adult Patient Results Day 1 |
Adult Patient Results Day 4 |
Adult Patient Results Day 8 |
Child Patient Results Day 1 |
Child Patient Results Day 5 |
Child Patient Results Day 8 |
| Seric glucose | 74 - 106 mg/dL | 99 | - | 100 | 87 | - | 82 |
| Blood urea nitrogen | 19.26 - 42.8 mg/dL | 52 | - | 33 | 16 | 26 | 30 |
| Seric creatinine | 0.66 - 1.25 mg/dL | 0.8 | - | 1.0 | 0.3 | 0.4 | 0.3 |
| Total Serum Protein | 6.3 - 8.2 g/dL | 7.1 | - | - | 7.3 | - | - |
| Sodium serum | 137 - 145 mmol/L | 139 | - | - | 137 | - | - |
| Potassium serum | 3.6 - 5.0 mmol/L | 4.6 | - | - | 4.0 | - | - |
| CKMB | 1-16 U/L | <3 | - | - | - | - | - |
| AST/TGO | 17 - 59 U/L | 105 | - | 79 | 61 | 46 | 40 |
| ALT/TGP | 4 - 50 U/L | 94 | - | 219 | 46 | 46 | 45 |
| LDH | 120 - 246 U/L | 272 | - | - | 302 | - | - |
| CK | 55 - 170 U/L | 132 | - | - | 82 | - | - |
| GGT | 15 - 73 U/L | 108 | - | 133 | - | - | - |
| Serum Lipase | 23 - 300 U/L | 63 | - | - | - | - | - |
| Serum albumin | 3.5 - 5 g/dL | 3.8 | - | - | 4.1 | - | - |
| Urine Erythrocytes | 1 - 17 /uL | 206 | - | - | - | - | - |
| Urine Leucocytes | 1 – 40 /uL | 5 | - | - | - | - | - |
| Urine Mucus | 0 – 4 /uL | 212 | - | - | 6 | - | - |
| Urine Epithelial Cells | 1 – 28 /uL | 3 | - | - | <1 | - | - |
| Urine Bacteria | Absent | relative frequent | - | - | - | - | - |
| Urine Ketones | Negative | Trace | - | - | Negative | - | - |
| Urine Nitrites | Negative | Negative | Negative | - | - | ||
| Urine Urobilinogen | Normal | Normal | Normal | - | - | ||
| Urine biliary | Negative | Negative | Negative | - | - | ||
| Urine Glucose | Normal | Normal | Normal | - | - | ||
| Urine Protein | Normal | Small | Normal | - | - | ||
| Urine Density | 1.015 - 1.030 | 1.025 | - | - | 1.010 | - | - |
| Urine pH | 5.5 - 6.5 | 5.5 | - | - | 5.5 | - | - |
| Urine Ascorbic Acid | Negative | Negative | - | - | Negative | - | - |
| C-reactive protein | 0 - 3.00 mg/l | 178 | 204 | 27 | 53.6 | 23.3 | 17.3 |
| White Blood Cells | 3.6 - 9.6 X10³/µL | 14. 23 | 11.04 | 7.84 | 11.5 | 12.1 | 11.9 |
| Neutrophils Count | 1.4 - 6.5X 10³/µL | 11.6 | 7.56 | 4.66 | 6.9 | 6.4 | 5.1 |
| Lymphocytes Count | 1.2 - 3.4 X10³/µL | 1.57 | 2.23 | 2.56 | 3.7 | 4.8 | 5.3 |
| Neutrophil / lymphocyte count rate | <3 | 7.42 | 3.39 | 1.82 | 1.82 | 1.33 | 0.96 |
| Monocytes Count | 0 - 0.7 X10³/µL | 0.72 | 0.85 | 0.35 | 0.9 | 0.9 | 1.3 |
| Eosinophils Count | 0 - 0.7 X10³/µL | 0.13 | 0.14 | 0.15 | 0.0 | 0.0 | 0.2 |
| Basophils Count | 0 - 0.2 X10³/µL | 0.01 | 0.03 | 0.02 | 0.1 | 0.1 | 0.1 |
| Red Blood Cells | 3.9 - 5.7 X100³/µL | 4.81 | 4.66 | 4.94 | 4.39 | 4.60 | 4.46 |
| Hemoglobin | 12.1 - 17.2 g/dl | 13.5 | 13.1 | 13.7 | 10.4 | 10.9 | 10.6 |
| HCT | 36.1 - 50.3% | 41.1 | 39.8 | 42.5 | 31.6 | 32.8 | 31.8 |
| MCV | 82 - 97.4 fL | 85.6 | 85.3 | 86.2 | 71.9 | 71.3 | 71.4 |
| MCH | 27.6 - 33.3 pg | 28.2 | 28.0 | 27.8 | 23.7 | 23.6 | 23.7 |
| MCHC | 33 - 34.8 g/dl | 32.9 | 32.8 | 32.2 | 32.9 | 33.0 | 33.2 |
| RDW | 11.6 - 13.7% | 13.8 | 14.1 | 13.9 | 16.4 | 16.4 | 16.6 |
| Platelets | 200 - 400 X10³/µL | 199000 | 217000 | 329000 | 299000 | 468000 | 501000 |
| MPV | 7.8 - 11 fl | 7.6 | 8.1 | 7.5 | 6.5 | 6.2 | 6.0 |
| HDW | 0 - 99.9% | 2.87 | 3.05 | 2.97 | - | - | 0.1 |
| PDW | 0 - 99.9% | 58.8 | 57.2 | 60.4 | 16.4 | 15.8 | 15.7 |
| PCT | 0 - 0.99% | 0.15 | 0.17 | 0.25 | - | 0.29 | 0.30 |
| APTT (sec) | 24 - 38 sec | 27.1 | - | - | - | - | - |
| PT (sec) | 10.5 - 13 sec | 11.4 | 11.4 | 11.0 | - | - | - |
| PT (%) | 80 - 115% | 99 | 99 | 104 | - | - | - |
| INR | 0.90 - 1.15 | 0.96 | 0.96 | 0.93 | - | - | - |
| FIBRINOGEN | 200 - 393 mg/dl | 963 | 919 | 535 | 405 | 328 | - |
| Procalcitonin | 0-0.5 pg | - | - | - | 0.73 | - | - |
| Urinary Legionella spp. antigen / Streptococcus pneumoniae | Negative | Urinary Legionella spp. Antigen - Positive Urinary Antigen Streptococcus pneumoniae- Negative |
- | - | Negative | - | - |
| Blood Culture | Negative | Negative | - | - | Negative- 2 samples | - | - |
- The results marked in red are out of normal reference levels.
References
- Personnic, N.; Striednig, B.; Hilbi, H. Legionella Quorum Sensing and Its Role in Pathogen–host Interactions. Curr. Opin. Microbiol. 2018, 41, 29–35. [CrossRef]
- García-Rodríguez, F.J.; Buchrieser, C.; Escoll, P. Legionella and Mitochondria, an Intriguing Relationship. Int. Rev. Cell Mol. Biol. 2023, 374, 37–81. [CrossRef]
- Whiley, H.; Bentham, R. Legionella Longbeachae and Legionellosis. Emerg. Infect. Dis. 2011, 17, 579–583. [CrossRef]
- Viasus, D.; Gaia, V.; Manzur-Barbur, C.; Carratalà, J. Legionnaires’ Disease: Update on Diagnosis and Treatment. Infect. Dis. Ther. 2022, 11, 973–986. [CrossRef]
- Liu, X.; Shin, S. Viewing Legionella Pneumophila Pathogenesis through an Immunological Lens. J. Mol. Biol. 2019, 431, 4321–4344. [CrossRef]
- Mascarenhas, D.P.; Zamboni, D.S. Innate Immune Responses and Monocyte-Derived Phagocyte Recruitment in Protective Immunity to Pathogenic Bacteria: Insights from Legionella Pneumophila. Curr. Opin. Microbiol. 2024, 80, 102495. [CrossRef]
- Surveillance Atlas of Infectious Diseases Available online: https://atlas.ecdc.europa.eu/public/index.aspx?Dataset=27&HealthTopic=30 (accessed on 4 March 2026).
- Prevalence of Legionella as a Waterborne Pathogen and Its Health Impacts in the Pan-European Region Available online: https://www.who.int/europe/publications/i/item/9789289062572 (accessed on 4 March 2026).
- European Centre for Disease Prevention and Control. Legionnaires’ Disease. ECDC. Annual Epidemiological Report 2021.
- Cooley, L.A.; Pondo, T.; Francois Watkins, L.K.; Shah, P.; Schrag, S.; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network Population-Based Assessment of Clinical Risk Factors for Legionnaires’ Disease. Clin. Infect. Dis. 2020, 70, 2428–2431. [CrossRef]
- Institutul Național de Sănătate Publică Available online: https://insp.gov.ro/centrul-national-de-supraveghere-si-control-al-bolilor-transmisibile-cnscbt/rapoarte-anuale/ 2023 (accessed on 18 February 2026).
- Institutul Național de Sănătate Publică Available online: https://insp.gov.ro/centrul-national-de-supraveghere-si-control-al-bolilor-transmisibile-cnscbt/rapoarte-anuale/ 2024 (accessed on 9 February 2026).
- Shim, J.Y. Current Perspectives on Atypical Pneumonia in Children. Clin. Exp. Pediatr. 2020, 63, 469–476. [CrossRef]
- CDC National Center for Immunization and Respiratory Diseases (NCIRD) Available online: https://www.cdc.gov/ncird/index.html (accessed on 9 February 2026).
- Redwitz, J.; Streich, P.; Zamfir, M.; Walser-Reichenbach, S.M.; Seidel, M.; Herr, C.E.W.; Heinze, S.; Quartucci, C. Verification and Application of qPCR and Viability-qPCR for Legionella Monitoring in Evaporative Cooling Systems Complementing the Conventional Culture Method. Sci. Total Environ. 2024, 953, 176011. [CrossRef]
- Dörrie, B.; Nogueira, R. Lessons Learned from a One-Year Study of Legionella Spp. Cultivation from Activated Sludge Samples. J. Environ. Manage. 2024, 369, 122266. [CrossRef]
- Vasile, C.-C.; Gheorghe, L.-A.; Chivu, C.-D.; Anghel, M.A.M.; Mîinea, Ștefan E.; Pițigoi, D.; Crăciun, M.-D. Clostridioides Difficile Infections and Antibiotherapy: Results of Four Years of Observation in a Romanian Tertiary Hospital. Microorganisms 2024, 12, 2490. [CrossRef]
- HOTARARE 657 18/05/2022 - Portal Legislativ Available online: https://legislatie.just.ro/Public/DetaliiDocument/255558 (accessed on 24 January 2026).
- EUR-Lex. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. https://eur-lex.europa.eu/.
- European Legionnaires’ Disease Surveillance Network (ELDSNet) Available online: https://www.ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eldsnet (accessed on 24 January 2026).
- Mukae, H.; Iwanaga, N.; Horita, N.; Komiya, K.; Maruyama, T.; Shindo, Y.; Imamura, Y.; Yatera, K.; Yamamoto, Y.; Yanagihara, K.; et al. The JRS Guideline for the Management of Pneumonia in Adults 2024. Respir. Investig. 2025, 63, 811–828. [CrossRef]
- Institutul Național de Sănătate Publică Available online: https://insp.gov.ro/centrul-national-de-supraveghere-si-control-al-bolilor-transmisibile-cnscbt/metodologii/ (accessed on 18 February 2026).
- Legionella.org. Legionnaires’ Disease in Children Available online: https://legionella.org/legionnaires-disease-in-children/ (accessed on 6 March 2026).
- van der Poll, T.; Opal, S.M. Pathogenesis, Treatment, and Prevention of Pneumococcal Pneumonia. Lancet 2009, 374, 1543–1556. [CrossRef]
- Orfanu, A.; Popescu, C.; Tilişcan, C.; Streinu-Cercel, A.; Aramă, V.; Aramă, Ş.S. The Usefulness of Neutrophil/lymphocyte Count Ratio in the Diagnosis and Prognosis of Bacterial Sepsis – An Old Parameter with New Implications. Rev. Romana Med. Lab. 2020, 28, 39–48. [CrossRef]
- Kline, M.W.; Orange, J.S.; Giardino, A.P.; Rathore, M.; Harris, Z.L.; Cabrera, A. Rudolph’s Pediatrics; 24th ed.; McGraw-Hill Education: Columbus, OH, 2026; ISBN 9781264277582.
- Correia, A.M.; Ferreira, J.S.; Borges, V.; Nunes, A.; Gomes, B.; Capucho, R.; Gonçalves, J.; Antunes, D.M.; Almeida, S.; Mendes, A.; et al. Probable Person-to-Person Transmission of Legionnaires’ Disease. N. Engl. J. Med. 2016, 374, 497–498. [CrossRef]



| Characteristic | Number of cases |
| Male | 20/32 |
| Female | 12/32 |
| Age group (years) | |
| 1-9 | 1/32 |
| 10-29 | 0/32 |
| 30-39 | 4/32 |
| 40-49 | 2/32 |
| 50-59 | 8/32 |
| 60-69 | 9/32 |
| >70 | 8/32 |
| Residence | |
| Bucharest (capital city) | 15/32 |
| Other districts | 17/32 |
| Variable | Cut offs |
Adult scoring |
Child scoring |
|
| A | Age | Male- over 65, Female over 75 | 0 | 0 |
| D | Dehydration | BUN over 21 mg/dl | 1 | 0 |
| R | Respiration | SO2 90% or less, PaO2 60 or less | 0 | 0 |
| O | Orientation | Affected consciousness | 0 | 0 |
| P | Systolic Blood Pressure | BP 90 mmHg or less | 0 | 0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).